KKR Group Finance Co. IX LLC 4.

KKR Group Finance Co. IX LLC 4.

KKRS
KKR Group Finance Co. IX LLC 4.US flagNew York Stock Exchange
16.19
USD
-0.09
- -
14.36BMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Joseph Bae
Sector
Financial Services
Industry
Financial - Credit Services
Address
30 Hudson Yards New York NY United States of America 10001
IPO Date
Apr 21, 2021
Website
kkr.com
Business
KKR Group Finance Co. IX LLC 4. (NYSE: KKRS) serves as a special purpose financing subsidiary within the KKR & Co. Inc. ecosystem, issuing junior subordinated debt securities to support the parent company's capital structure and funding needs for its global alternative asset management activities; it issued $500 million of 4.625% junior subordinated notes due April 1, 2061, which rank below senior debt and provide long-term financing for KKR's operations spanning private equity, private credit, real estate, infrastructure, and insurance solutions. Headquartered in New York and founded as part of KKR's structure originating from the 1976 establishment of KKR & Co. Inc., the entity facilitates capital raising and debt management for KKR's investment strategies targeting institutional investors worldwide across North America, Europe, Asia-Pacific, and emerging markets. Recent developments include KKR's ongoing subordinated notes offerings, such as the May 2025 announcement of notes due 2065, alongside parent company capital raises exceeding $43 billion in Q3 2025 and the acquisition of Healthcare Royalty Partners, bolstering fee-paying assets under management toward $446 billion as of late 2024.